COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA

INHIBITION OF SMOOTH MUSCLE CELL CONTRACTION BY ALTERING INTERLEUKIN 31 RECEPTOR ALPHA LEVELS

VIRAL VECTOR MEDIATED GENE THERAPY TRANSDUCTION AND SAFETY OR PROMOTING VIRAL CLEARANCE AND/OR INHIBITING VIRAL INFECTIVITY BY TARGETING CLASS B SCAVENGER RECEPTORS

METHODS OF TREATING IMPAIRED GLUCOCORTICOID SIGNALLING IN UTERINE DISORDERS

CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE-MEDIATED KNOCKDOWN OF PLN

OLIGONUCLEOTIDE-MEDIATED KNOCKDOWN OF DUX4

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

INTERFERING RNA FOR INHIBITING JAK1 GENE EXPRESSION AND USE THEREOF

ATTENUATION OF CYTOKINE RELEASE SYNDROME IN IMMUNOTHERAPY

ATTENUATION OF CYTOKINE RELEASE SYNDROME IN

INVERTED CHIMERIC siRNA MOLECULES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME

SMALL RNA-BASED PROGNOSTIC SIGNATURES AND THERAPEUTIC COMPOSITIONS FOR IDIOPATHIC PULMONARY FIBROSIS

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

COMPOSITION AND METHOD FOR TREATING CANCER WITH CHROMOSOME TRANSLOCATION FUSION

PLIN1 RNAi INTERFERENCE AGENTS

RNAi Agent Targeting PCSK9 and Use Thereof

INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF

ANTI-CANCER TGFB2 AGENTS WITH IMMUNOTHERAPEUTICS

NANOCOMPLEX TARGETING NERVOUS NECROSIS VIRUS AS WELL AS PREPARATION METHOD AND USE THEREOF

RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compositions Thereof, and Methods of Use

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS

COMPOSITIONS AND METHODS FOR DELIVERING A MACROMOLECULE TO A CELL

POLYNUCLEOTIDES FOR SILENCING TRANSCRIPT VARIANT 1 OF ASSEMBLY FACTOR FOR SPINDLE MICROTUBULES AND APPLICATIONS THEREOF

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS

RNAi AGENTS FOR MODULATING SNCA

STABILIZED RNA AGENTS

GENE THERAPY FOR PRADER WILLI SYNDROME

METHODS OF TREATING CANCERS

RNA THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATION OF CFTR

THERAPEUTIC AGENT FOR TREATING HIF-1alpha-MEDIATED DISEASES BY INHIBITING AREL1 AND RESTORING PHD2 ACTIVITY

TREATMENT OF CANCERS HAVING A DRUG-RESISTANT MESENCHYMAL CELL STATE

CHEMICAL MODIFICATIONS OF SMALL INTERFERING RNA WITH MINIMAL FLUORINE CONTENT

DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF

FINE-TUNING INFLAMMATION BY ALTERING 3'UTR LENGTH

COMPOSITIONS FOR AQUACULTURING

PLATELETS TRANSFECTED WITH SIRNA AND THE THERAPEUTICS USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING MYOPATHY

MODULATORY POLYNUCLEOTIDES

SURF4 GENE KNOCKOUT ERYTHROID PROGENITOR CELLS AND METHODS OF ERYTHROID DIFFERENTIATION THEREOF

MEANS TO TREAT AUTOIMMUNITY BY REFINING REGULATORY T CELLS

EPO RECEPTOR AGONISTS AND ANTAGONISTS

METHODS AND COMPOSITIONS FOR TREATING CORNEAL WOUNDS

DRUG DELIVERY SYSTEM FOR BLOOD-BRAIN BARRIER PENETRATION

POLYMER DERIVATIVES AND THEIR USE AS LIPID NANOPARTICLE MODIFIERS

LIPID NANOPARTICLES

COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS

PREPARATION AND USE OF NUCLEIC ACID WITH ANTI-HAIR LOSS AND OIL CONTROL EFFECTS AND COMPOSITION INCLUDING NUCLEIC ACID

METHODS, SYSTEMS, AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHY (E.G., BETA-THALASSEMIA AND SICKLE CELL DISEASE) BY INCREASING EXPRESSION OF NONCODING RNA ACTIVATED BY DNA DAMAGE

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

OLIGONUCLEOTIDES FOR MAPT MODULATION

Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction

METHODS AND COMPOSITIONS FOR SELECTIVE REGULATION OF PROTEIN EXPRESSION

ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF CANAVAN DISEASE

C-MYC-TARGETING CHARGE-ALTERING RELEASABLE TRANSPORTERS AS ANTI-TUMOR AGENTS FOR BREAST CANCER THERAPY

NOVEL COMPOUND AND APPLICATION THEREOF

NOVEL COMPOUND AND APPLICATION THEREOF

siRNA COMPOSITIONS AND METHODS TARGETING ALPHA-SYNUCLEIN NUCLEIC ACIDS

KLRG1 SIGNALLING THERAPY FOR INFECTIOUS DISEASE

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING

METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROINFLAMMATORY DISEASES

COMPOSITIONS AND METHODS TO TREAT ALZHEIMER'S DISEASE AND OTHER BRAIN DISEASES

METHODS AND COMPOSITIONS FOR DESIGNING AND SELECTING TINYRNAS TO MAXIMIZE TARGET CLEAVAGE

COMPOSITIONS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIAS

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

MODIFIED DOUBLE-STRANDED RNA AGENTS

INDUCTION OF STEM-LIKE ACTIVATED T CELLS

ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

DNA-RNA HETERODUPLEX TARGETING ANDROGEN RECEPTOR

METHODS FOR TREATMENT OF ANEMIA

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF

Carbohydrate-oligonucleotide conjugates, pharmaceutical compositions, and therapeutic applications

PRODUCTS AND COMPOSITIONS

TREATMENT OF THYMIC STROMAL LYMPHOPOIETIN (TSLP) RELATED DISEASES BY INHIBITION OF LONG-FORM TSLP TRANSCRIPTS

MICRORNA AND USES THEREOF IN PREVENTION AND/OR TREATMENT OF FIBROPLASIA MEDICAL SIGN AND/OR SYNDROME

IRON METABOLISM TARGETS FOR OBESITY

GALNAC MONOMER COMPRISING RIBOSE RING OR DERIVATIVE STRUCTURE THEREOF AND USE THEREOF IN LIVER-TARGETED DELIVERY OF SMALL NUCLEIC ACID DRUGS

SIRNA FOR TARGETED INHIBITION OF AGT GENE EXPRESSION AND USE THEREOF IN TREATING HYPERTENSION

USE OF HOMEOBOX CONTAINING 1 (HMBOX1) INHIBITOR IN PREPARATION OF DRUG FOR PREVENTION AND/OR TREATMENT OF MUSCLE ATROPHY

CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF

DOWNREGULATING INOS TO INCREASE CAR-T KILLING

Methods for Directing Lipid Nanoparticles in Vivo

RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of Use

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

Method of Inhibiting Durotaxis and/or Treating Fibrosis

DSRNA, USE THEREOF AND PREPARATION METHOD THEREFOR

MATERIALS AND PROCESSES FOR ENGINEERING HYPOIMMUNOGENICITY

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE

CONJUGATE OF NUCLEOTIDE ANALOG-CONTAINING DOUBLE-STRANDED RNAI ANALOG

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES

COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS

RNA INTERFERENCE (RNAI) FOR CONTROL OF JAPANESE BEETLE

METHODS FOR IMPROVING PRODUCTION OF BIOLOGICAL PRODUCTS BY REDUCING THE LEVEL OF ENDOGENOUS PROTEIN

Treatment Of Pan-Cancer Phenotype With Regulator of Telomere Elongation Helicase 1 (RTEL1) Inhibitors

TREATMENT FOR OVARIAN CANCER WITH OLIGONUCLEOTIDES TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS OF TREATING RETINAL DEGENERATIVE DISEASES

LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF

USE OF PGAM2 IN BREEDING OF BLCATTLE BLACK CATTLE

MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS

COMPOSITIONS AND METHODS FOR INHIBITING XDH EXPRESSION

REVERSIR MOLECULES AND METHODS OF USE THEREOF

SIRNA TARGETING ANGPTL4, AND CONJUGATES AND USES THEREOF

EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A DUAL CLEAVABLE LINKER

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

COMPOUNDS AND METHODS FOR TREATING HUMAN SUBJECTS

COMPOSITIONS AND METHODS FOR TREATING NONALCOHOLIC FATTY LIVER DISEASE

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

NONCODING RNA AGENTS (BCYRN1 AND DERIVATIVES THEREOF) TO TREAT DISEASES OF IMMUNITY

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

Therapeutic Strategies To Reduce Thrombotic Risk In Factor V Leiden (FVL) Carriers

TREM2 BINDS TO SPECIFICALLY STRUCTURED HEPARAN SULFATE

ANTISENSE OLIGONUCLEOTIDE-BASED ANTI-FIBROTIC THERAPEUTICS

REGULATION OF ACTIVITY OF RNAI MOLECULES

EXPRESSION OF FC-CONTAINING PROTEINS

COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

Inhibition of TCF4/ITF2 in the Treatment of Cancer

METHODS OF ALTERING THE STARCH GRANULE PROFILE IN PLANTS

COMPOSITIONS AND METHODS FOR INHIBITING ADENYLATE CYCLASE 9 (AC9)

Oligonucleotide for reducing the expression of leucine-rich repeat kinase 2 (LRRK2) and its use for preventing and/or treating human diseases

RNAi Agents for Inhibiting Expression of Thymic Stromal Lymphopoietin (TSLP), Compositions Thereof, and Methods of Use

LINKER, COMPOUND INCLUDING LINKER, METHOD OF PREPARING COMPOUND, USE OF LINKER, AND METHOD OF DELIVERING OLIGONUCLEOTIDES THROUGH LINKER

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

METHODS FOR TREATING ENDOMETRIAL AND OVARIAN HYPERPROLIFERATIVE DISORDERS

VIRAL VECTOR

AGENTS THAT INHIBIT CCN LIGAND-INDUCED SIGNALLING FOR TREATING DISEASE

SIRNA TARGETING KEY GENE OF MAGNAPORTHE ORYZAE FOR CONTROLLING RICE BLAST, AND USE THEREOF

PLASMINOGEN (PLG) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TARGETING SERINE DEHYDRATASE

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

OLIGONUCLEOTIDES FOR PRNP MODULATION

COMBINATION TREATMENT FOR CANCER

SYSTEMS AND METHODS FOR TARGETING NAD-BASED PATHWAYS FOR TREATMENT OF CANCER

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

HYBRID OLIGONUCLEOTIDES

AGENTS FOR MODULATING EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

RNAi AGENTS OF PRION EXPRESSION

POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES

B CELL-SPECIFIC MAB-SIRNA CONJUGATES IMPROVE MYASTHENIA

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF

SUBPOPULATION-DIRECTED REMEDIATION OF DISEASE-ASSOCIATED GENE PRODUCTS

RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use

GENETIC MODULATORS OF KRAS PROTEIN EXPRESSION AND THEIR USES

Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SIRNA AS ACTIVE INGREDIENT

POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

TAU-SEED INTERACTOR INHIBTORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

METHODS AND COMPOSITIONS FOR SELECTIVELY MODULATING GENE EXPRESSION IN MEGAKARYOCYTES AND PLATELETS

METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES

1'-ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE

LIPID NANOPARTICLE AND PHARMACEUTICAL COMPOSITION

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

SPERMATOGENESIS ALTERATION

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

NOVEL STAPLE NUCLEIC ACID

COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY

RNA-BASED CONTROL OF PRODUCTION OF DEOXYNIVALENOL BY FUSARIUM

RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use

INHIBITORS OF EXPRESSION AND/OR FUNCTION

GALNAC COMPOUND CONTAINING RIBOSE RING OR ITS DERIVATIVE STRUCTURE AND OLIGONUCLEOTIDE CONJUGATE THEREOF

COMPOUND FOR INHIBITING AGT GENE EXPRESSION, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

COMPOUND FOR INHIBITING EXPRESSION OF LPA GENE, PHARMACEUTICAL COMPOSITION AND USE THEREOF

DESIGN AND APPLICATION OF NOVEL PHOTORECEPTOR-SPECIFIC PROMOTERS FOR RETINAL GENE THERAPY APPLICATIONS

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

Neutral Liposomes Containing Biologically Active Agents

ADAM32 GENE IN THE DIAGNOSIS AND TREATMENT OF LUNG ADENOCARCINOMA

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

SIRNA TARGETING AND REGULATING PCSK9 GENE EXPRESSION AND USE THEREOF

MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF

MODULAR RNA DELIVERY PLATFORMS AND METHODS OF THEIR USE

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

COMPOUNDS AND METHODS FOR REDUCING PRION EXPRESSION

COMPOSITIONS AND METHOD FOR THE TREATMENT OF X-LINKED DYSTONIA PARKINSONISM

Antisense Nucleic Acids for Use in the Treatment for LMNA Mutation Carriers

METHODS AND COMPOSITIONS FOR WOUND HEALING

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

IONIZABLE LIPID CONTAINING BIODEGRADABLE DISULFIDE BOND AND LIPID NANOPARTICLES COMPRISING SAME

METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE

METHODS AND COMPOSITIONS FOR INTRON MEDIATED- EXPRESSION OF REGULATORY ELEMENTS FOR TRAIT DEVELOPMENT

ANTISENSE OLIGOMERS FOR TREATMENT OF NON-SENSE MEDIATED RNA DECAY BASED CONDITIONS AND DISEASES

ADVANCED RNA TARGETING (ARNATAR)

Compositions and Methods for Inhibition of Factor XII Gene Expression

RNA INTERFERENCE OLIGONUCLEOTIDES FOR INHIBITING PERINEURONAL NETWORK FORMATION

NUCLEIC ACID COMPOUNDS

EPO RECEPTOR AGONISTS AND ANTAGONISTS

RNA-DNA FUSOMERS AND METHODS OF USE THEREOF

DOUBLE-STRANDED RNA COMPRISING NUCLEOTIDE ANALOG CAPABLE OF REDUCING OFF-TARGET TOXICITY

METHODS OF IMPROVING SYSTEMIC DISEASE OUTCOMES BY INHIBITION OF ZHX2

IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

LOX3 GENE MODULATION AND ARMYWORM TOLERANCE

IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY

SIRNA TARGETING RECQL1 HELICASE GENE

METHODS AND COMPOSITIONS FOR INHIBITING VIRUS

DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND METHODS RELATING THERETO

SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF

NOVEL RNA THERAPEUTICS AND USES THEREOF

MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY

PRNP RNAi AGENTS

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

HAPLOID INDUCTION COMPOSITIONS AND METHODS FOR USE THEREFOR

RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of Use

MULTI-FUNCTIONAL NEAR-INFRARED FLUORESCENT POLYMER DOT-SIRNA FOR GENE EXPRESSION REGULATION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN

NUCLEIC ACID COMPOUNDS

METHODS AND COMPOSITIONS FOR INHIBITION OF IRF4

THERAPEUTIC AGENT FOR CANCER, TESTING ASSISTANCE METHOD, AND SCREENING METHOD FOR THERAPEUTIC AGENT

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

METHODS AND COMPOSITIONS RELATED TO ASSESSMENT AND TREATMENT OF KIDNEY DISEASE

IMPROVED RECOMBINANT ADENO-ASSOCIATED VIRUS PRODUCTION

NUCLEOTIDE ANALOGUES, AND PREPARATION AND APPLICATION THEREOF

Compositions and Methods for GYS1 Inhibition

COMPOSITIONS AND METHODS FOR CONTROL OF PSEUDOGYMNOASCUS DESTRUCTANS

NUCLEIC ACID COMPOUNDS

TREATMENT OF MS4A4E RELATED DISEASES AND DISORDERS

COMPOSITION COMPRISING TAF10 INHIBITOR FOR PREVENTING OR TREATING COLORECTAL CANCER

SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

Targeted Nanomedicine for Treating Fibrotic Lung Disorders

Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto

GENE EDITING SYSTEM FOR TREATING DUCHENNE MUSCULAR DYSTROPHY, AND METHOD OF TREATING DISEASE USING SAME

METHODS AND COMPOSITIONS FOR PRODUCING SELF-AMPLIFYING RNA FOR GENE SILENCING IN PLANTS

RNA VECTORS WITH HAIRPIN-LIKE INSERTS

NANOPARTICLE COMPOSITIONS CONTAINING SIRP-alpha siRNA FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES

POLYNUCLEIC ACID MOLECULES TARGETING AGT AND USES THEREOF

MODIFIED U7 SNRNA CONSTRUCT

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

POPULATION OF TRANSFECTED IMMUNE CELLS AND METHOD FOR THEIR PRODUCTION

Compositions and Methods for Treating Cancer

INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE

TARGETING ARHGAP5 GENE FUNCTION IN CANCER WITH ARHGAP35 ALTERATION

CALCIUM SALTED SPHERICAL NUCLEIC ACIDS

Ligand-Modified Oligonucleotides

METHOD FOR TREATMENT OF MYOTONIC DYSTROPHY COMBINING PROTEIN EXPRESSION AND RNA INTERFERENCE VECTOR DELIVERY WITH TISSUE DETARGETING

COMPOSITIONS COMPRISING PLN-TARGETING ANTI-TRANSFERRIN RECEPTOR ANTIBODY-POLYNUCLEOTIDES AND METHODS OF USE THEREOF TO TREAT CARDIOMYOPATHY

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

INTERFERING RNA THERAPY FOR PLN-R14del CARDIOMYOPATHY

CCR5 and CD4 siRNA-TARGETED PHOSPHOLIPID NANOSOMES THERAPEUTICS FOR TREATMENT OF HIV-1 AND OTHER DISEASES

RNAI AGENT INHIBITING PCSK9 GENE EXPRESSION AND APPLICATION THEREOF

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING FOXM1 MUTANT OR FOXM1 SHRNA

Linkage Modified Oligomeric Compounds and Uses Thereof

COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSATELLITE DNA EXPANSION DISORDERS

TARGETING MICRO RNA FOR TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

MODIFIED NUCLEIC ACID CONJUGATES

LEUKEMIA TREATMENT

EXTRACELLULAR VESICLES COMPRISING SMALL INTERFERING RNA

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 (VEGFR-1) INHIBITORS FOR PROMOTING MYELINATION AND NEUROPROTECTION

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

COMPOSITIONS AND METHODS FOR MODULATING CONDITIONS ASSOCIATED WITH ALTERED ATP8B1 FUNCTION

ANTISENSE OLIGOMERS AGAINST MONOAMINE OXIDASE B AND USE THEREOF

ANTISENSE OLIGONUCLEOTIDES

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING FOXM1 MUTANT OR FOXM1 SHRNA

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

SIRNA MOLECULE AGAINST HUMAN TENASCIN-C (TNC) AND A PHARMACEUTICAL COMPOSITION COMPRISING IT

COMPOUNDS AND METHODS FOR REDUCING PCDH19 EXPRESSION

Method for Treating Cyclophilin D Associated Diseases

COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION

COMPOSITION FOR CONTROLLING DNA DAMAGE REPAIR EFFICIENCY

GLIOBLASTOMA TUMOR GROWTH INHIBITON BY SAT1 KNOCKDOWN

USE OF INTERFERING RNAS DIRECTED AGAINST THE CHOLINERGIC SYSTEM FOR CONTROLLING INSECT PESTS

TREATING TUBEROUS SCLEROSIS COMPLEX-ASSOCIATED DISEASES

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

COMPOSITION FOR REGULATING SPLICING OF POLYBROMO 1 GENE COMPRISING SPLICING-SWITCH OLIGONUCLEOTIDE AS EFFECTIVE COMPONENT

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF ANGPTL3, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF

ANTI-PVRIG ANTIBODIES AND METHODS OF USE

CARDIOPROTECTIVE HEART DISEASE THERAPIES

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING GLIOBLASTOMAS

INHIBITION OF HISTONE METHYL TRANSFERASES TO TREAT CANCER

LPA-TARGETING SIRNA AND CONJUGATE

IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES

SCREENING METHODS FOR TARGETS FOR CANCER THERAPY

METHOD FOR TESTING PULMONARY HYPERTENSION, PATHOLOGICAL ANIMAL MODEL FOR PULMONARY ARTERIAL HYPERTENSION, AND PREVENTIVE OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION

METHOD FOR CARDIAC REPAIR

Compositions for and Methods Creating Exon-Skipped mRNA Producing Internal Controls

ANTISENSE MODULATION OF SETBP1 EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT FACTOR B

ROLE OF POLYPHOSPHATES IN NEUROLOGICAL DISORDERS

AGENT FOR AVOIDING IMMUNE RESPONSE OF TRANSGENIC CELLS

COMPOSITIONS AND METHODS FOR REDUCING CELL THERAPY IMMUNOGENICITY

POLYVALENT MOLECULE BASED LIPID NANOPARTICLES FOR NUCLEIC ACID DELIVERY

METHOD FOR PROMOTING SEXUAL MATURATION OF FISH